nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—Abnormal faeces—Varenicline—nicotine dependence	0.0311	0.0397	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0206	0.0951	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0196	0.0901	CbGpPWpGaD
Tiagabine—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0181	0.0231	CcSEcCtD
Tiagabine—Hostility—Varenicline—nicotine dependence	0.016	0.0205	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CHRNB3—nicotine dependence	0.0158	0.0728	CbGpPWpGaD
Tiagabine—Suicide attempt—Varenicline—nicotine dependence	0.0156	0.02	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CHRNA6—nicotine dependence	0.015	0.069	CbGpPWpGaD
Tiagabine—Libido increased—Varenicline—nicotine dependence	0.0146	0.0186	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0141	0.0651	CbGpPWpGaD
Tiagabine—Psoriasis—Varenicline—nicotine dependence	0.0141	0.018	CcSEcCtD
Tiagabine—Parosmia—Varenicline—nicotine dependence	0.0137	0.0175	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0136	0.0625	CbGpPWpGaD
Tiagabine—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0136	0.0173	CcSEcCtD
Tiagabine—Paranoia—Varenicline—nicotine dependence	0.013	0.0166	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0126	0.0581	CbGpPWpGaD
Tiagabine—Delusion—Varenicline—nicotine dependence	0.0125	0.016	CcSEcCtD
Tiagabine—Nystagmus—Varenicline—nicotine dependence	0.0124	0.0159	CcSEcCtD
Tiagabine—Hyperlipidaemia—Varenicline—nicotine dependence	0.0123	0.0157	CcSEcCtD
Tiagabine—Menorrhagia—Varenicline—nicotine dependence	0.012	0.0153	CcSEcCtD
Tiagabine—Scotoma—Varenicline—nicotine dependence	0.0117	0.0149	CcSEcCtD
Tiagabine—Gingivitis—Varenicline—nicotine dependence	0.0113	0.0144	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—GABRA4—nicotine dependence	0.0108	0.0499	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNB4—nicotine dependence	0.0104	0.0479	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0103	0.0473	CbGpPWpGaD
Tiagabine—Disturbance in attention—Varenicline—nicotine dependence	0.0103	0.0131	CcSEcCtD
Tiagabine—Accidental injury—Varenicline—nicotine dependence	0.01	0.0128	CcSEcCtD
Tiagabine—Thinking abnormal—Varenicline—nicotine dependence	0.0097	0.0124	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CHRNA5—nicotine dependence	0.00966	0.0445	CbGpPWpGaD
Tiagabine—Nocturia—Varenicline—nicotine dependence	0.00957	0.0122	CcSEcCtD
Tiagabine—Dysarthria—Varenicline—nicotine dependence	0.00939	0.012	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00904	0.0417	CbGpPWpGaD
Tiagabine—Coordination abnormal—Varenicline—nicotine dependence	0.00904	0.0115	CcSEcCtD
Tiagabine—Abnormal dreams—Varenicline—nicotine dependence	0.00878	0.0112	CcSEcCtD
Tiagabine—Eructation—Varenicline—nicotine dependence	0.00872	0.0111	CcSEcCtD
Tiagabine—Salivary hypersecretion—Varenicline—nicotine dependence	0.00862	0.011	CcSEcCtD
Tiagabine—Photophobia—Varenicline—nicotine dependence	0.00834	0.0106	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00821	0.0378	CbGpPWpGaD
Tiagabine—Oesophagitis—Varenicline—nicotine dependence	0.00811	0.0104	CcSEcCtD
Tiagabine—Mouth ulceration—Varenicline—nicotine dependence	0.00803	0.0103	CcSEcCtD
Tiagabine—Urine output increased—Varenicline—nicotine dependence	0.00803	0.0103	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CHRNA3—nicotine dependence	0.00787	0.0363	CbGpPWpGaD
Tiagabine—Hypertonia—Varenicline—nicotine dependence	0.00778	0.00994	CcSEcCtD
Tiagabine—Mental disability—Varenicline—nicotine dependence	0.00771	0.00984	CcSEcCtD
Tiagabine—Euphoric mood—Varenicline—nicotine dependence	0.00763	0.00974	CcSEcCtD
Tiagabine—Lymphadenopathy—Varenicline—nicotine dependence	0.00756	0.00965	CcSEcCtD
Tiagabine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00746	0.0344	CbGpPWpGaD
Tiagabine—Polyuria—Varenicline—nicotine dependence	0.00734	0.00938	CcSEcCtD
Tiagabine—Deafness—Varenicline—nicotine dependence	0.00721	0.0092	CcSEcCtD
Tiagabine—Eczema—Varenicline—nicotine dependence	0.00717	0.00916	CcSEcCtD
Tiagabine—Eye pain—Varenicline—nicotine dependence	0.00714	0.00912	CcSEcCtD
Tiagabine—Injury—Varenicline—nicotine dependence	0.00701	0.00896	CcSEcCtD
Tiagabine—Libido decreased—Varenicline—nicotine dependence	0.00695	0.00888	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CHRNB2—nicotine dependence	0.00693	0.0319	CbGpPWpGaD
Tiagabine—Increased appetite—Varenicline—nicotine dependence	0.00686	0.00876	CcSEcCtD
Tiagabine—Thirst—Varenicline—nicotine dependence	0.00677	0.00865	CcSEcCtD
Tiagabine—Arthritis—Varenicline—nicotine dependence	0.00663	0.00847	CcSEcCtD
Tiagabine—Hypoglycaemia—Varenicline—nicotine dependence	0.00661	0.00844	CcSEcCtD
Tiagabine—Osteoarthritis—Varenicline—nicotine dependence	0.00645	0.00823	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00645	0.00823	CcSEcCtD
Tiagabine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00639	0.00817	CcSEcCtD
Tiagabine—Affect lability—Varenicline—nicotine dependence	0.00634	0.0081	CcSEcCtD
Tiagabine—Migraine—Varenicline—nicotine dependence	0.00634	0.0081	CcSEcCtD
Tiagabine—Psychotic disorder—Varenicline—nicotine dependence	0.0063	0.00804	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—CHRNA4—nicotine dependence	0.00629	0.029	CbGpPWpGaD
Tiagabine—Irritability—Varenicline—nicotine dependence	0.00615	0.00786	CcSEcCtD
Tiagabine—Urinary retention—Varenicline—nicotine dependence	0.00613	0.00783	CcSEcCtD
Tiagabine—Mood swings—Varenicline—nicotine dependence	0.00611	0.0078	CcSEcCtD
Tiagabine—Liver function test abnormal—Varenicline—nicotine dependence	0.00595	0.0076	CcSEcCtD
Tiagabine—Dry skin—Varenicline—nicotine dependence	0.00591	0.00755	CcSEcCtD
Tiagabine—Hypokalaemia—Varenicline—nicotine dependence	0.00587	0.00749	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00582	0.0268	CbGpPWpGaD
Tiagabine—Gastritis—Varenicline—nicotine dependence	0.0057	0.00729	CcSEcCtD
Tiagabine—Asthma—Varenicline—nicotine dependence	0.00557	0.00712	CcSEcCtD
Tiagabine—Dysphagia—Varenicline—nicotine dependence	0.00557	0.00712	CcSEcCtD
Tiagabine—Angina pectoris—Varenicline—nicotine dependence	0.00543	0.00693	CcSEcCtD
Tiagabine—Bronchitis—Varenicline—nicotine dependence	0.00536	0.00684	CcSEcCtD
Tiagabine—Pollakiuria—Varenicline—nicotine dependence	0.00515	0.00657	CcSEcCtD
Tiagabine—Erectile dysfunction—Varenicline—nicotine dependence	0.00513	0.00655	CcSEcCtD
Tiagabine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00509	0.00649	CcSEcCtD
Tiagabine—Weight increased—Varenicline—nicotine dependence	0.00507	0.00648	CcSEcCtD
Tiagabine—Hyperglycaemia—Varenicline—nicotine dependence	0.00503	0.00642	CcSEcCtD
Tiagabine—Depression—Varenicline—nicotine dependence	0.00495	0.00633	CcSEcCtD
Tiagabine—Acute coronary syndrome—Varenicline—nicotine dependence	0.0049	0.00625	CcSEcCtD
Tiagabine—Myocardial infarction—Varenicline—nicotine dependence	0.00487	0.00622	CcSEcCtD
Tiagabine—Stomatitis—Varenicline—nicotine dependence	0.00484	0.00618	CcSEcCtD
Tiagabine—Conjunctivitis—Varenicline—nicotine dependence	0.00483	0.00617	CcSEcCtD
Tiagabine—Epistaxis—Varenicline—nicotine dependence	0.00469	0.00598	CcSEcCtD
Tiagabine—Sinusitis—Varenicline—nicotine dependence	0.00466	0.00595	CcSEcCtD
Tiagabine—Hypoaesthesia—Varenicline—nicotine dependence	0.00444	0.00567	CcSEcCtD
Tiagabine—Hallucination—Varenicline—nicotine dependence	0.00444	0.00567	CcSEcCtD
Tiagabine—Oedema peripheral—Varenicline—nicotine dependence	0.00439	0.00561	CcSEcCtD
Tiagabine—Visual impairment—Varenicline—nicotine dependence	0.0043	0.00549	CcSEcCtD
Tiagabine—Tinnitus—Varenicline—nicotine dependence	0.00416	0.00531	CcSEcCtD
Tiagabine—Chills—Varenicline—nicotine dependence	0.004	0.00511	CcSEcCtD
Tiagabine—Flatulence—Varenicline—nicotine dependence	0.00383	0.00489	CcSEcCtD
Tiagabine—Dysgeusia—Varenicline—nicotine dependence	0.0038	0.00486	CcSEcCtD
Tiagabine—Back pain—Varenicline—nicotine dependence	0.00375	0.0048	CcSEcCtD
Tiagabine—Muscle spasms—Varenicline—nicotine dependence	0.00373	0.00477	CcSEcCtD
Tiagabine—Tremor—Varenicline—nicotine dependence	0.00364	0.00465	CcSEcCtD
Tiagabine—Ill-defined disorder—Varenicline—nicotine dependence	0.0036	0.0046	CcSEcCtD
Tiagabine—Anaemia—Varenicline—nicotine dependence	0.00359	0.00458	CcSEcCtD
Tiagabine—Agitation—Varenicline—nicotine dependence	0.00357	0.00456	CcSEcCtD
Tiagabine—Malaise—Varenicline—nicotine dependence	0.0035	0.00447	CcSEcCtD
Tiagabine—Vertigo—Varenicline—nicotine dependence	0.00349	0.00445	CcSEcCtD
Tiagabine—Syncope—Varenicline—nicotine dependence	0.00348	0.00445	CcSEcCtD
Tiagabine—Palpitations—Varenicline—nicotine dependence	0.00343	0.00438	CcSEcCtD
Tiagabine—Loss of consciousness—Varenicline—nicotine dependence	0.00341	0.00436	CcSEcCtD
Tiagabine—Cough—Varenicline—nicotine dependence	0.00339	0.00433	CcSEcCtD
Tiagabine—Hypertension—Varenicline—nicotine dependence	0.00335	0.00428	CcSEcCtD
Tiagabine—Myalgia—Varenicline—nicotine dependence	0.0033	0.00422	CcSEcCtD
Tiagabine—Arthralgia—Varenicline—nicotine dependence	0.0033	0.00422	CcSEcCtD
Tiagabine—Chest pain—Varenicline—nicotine dependence	0.0033	0.00422	CcSEcCtD
Tiagabine—Anxiety—Varenicline—nicotine dependence	0.00329	0.00421	CcSEcCtD
Tiagabine—Discomfort—Varenicline—nicotine dependence	0.00327	0.00417	CcSEcCtD
Tiagabine—Dry mouth—Varenicline—nicotine dependence	0.00323	0.00413	CcSEcCtD
Tiagabine—Oedema—Varenicline—nicotine dependence	0.00317	0.00405	CcSEcCtD
Tiagabine—Infection—Varenicline—nicotine dependence	0.00315	0.00402	CcSEcCtD
Tiagabine—Shock—Varenicline—nicotine dependence	0.00312	0.00398	CcSEcCtD
Tiagabine—Thrombocytopenia—Varenicline—nicotine dependence	0.0031	0.00396	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0031	0.0143	CbGpPWpGaD
Tiagabine—Tachycardia—Varenicline—nicotine dependence	0.00309	0.00395	CcSEcCtD
Tiagabine—Hyperhidrosis—Varenicline—nicotine dependence	0.00306	0.00391	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00306	0.0141	CbGpPWpGaD
Tiagabine—Anorexia—Varenicline—nicotine dependence	0.00302	0.00386	CcSEcCtD
Tiagabine—Hypotension—Varenicline—nicotine dependence	0.00296	0.00378	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00289	0.00369	CcSEcCtD
Tiagabine—Insomnia—Varenicline—nicotine dependence	0.00287	0.00366	CcSEcCtD
Tiagabine—Dyspnoea—Varenicline—nicotine dependence	0.00282	0.00361	CcSEcCtD
Tiagabine—Somnolence—Varenicline—nicotine dependence	0.00282	0.0036	CcSEcCtD
Tiagabine—Dyspepsia—Varenicline—nicotine dependence	0.00279	0.00356	CcSEcCtD
Tiagabine—Decreased appetite—Varenicline—nicotine dependence	0.00275	0.00352	CcSEcCtD
Tiagabine—Fatigue—Varenicline—nicotine dependence	0.00273	0.00349	CcSEcCtD
Tiagabine—Pain—Varenicline—nicotine dependence	0.00271	0.00346	CcSEcCtD
Tiagabine—Constipation—Varenicline—nicotine dependence	0.00271	0.00346	CcSEcCtD
Tiagabine—Feeling abnormal—Varenicline—nicotine dependence	0.00261	0.00333	CcSEcCtD
Tiagabine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00259	0.00331	CcSEcCtD
Tiagabine—Urticaria—Varenicline—nicotine dependence	0.00252	0.00321	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00251	0.0116	CbGpPWpGaD
Tiagabine—Abdominal pain—Varenicline—nicotine dependence	0.0025	0.0032	CcSEcCtD
Tiagabine—Body temperature increased—Varenicline—nicotine dependence	0.0025	0.0032	CcSEcCtD
Tiagabine—Hypersensitivity—Varenicline—nicotine dependence	0.00233	0.00298	CcSEcCtD
Tiagabine—Asthenia—Varenicline—nicotine dependence	0.00227	0.0029	CcSEcCtD
Tiagabine—Pruritus—Varenicline—nicotine dependence	0.00224	0.00286	CcSEcCtD
Tiagabine—Diarrhoea—Varenicline—nicotine dependence	0.00217	0.00277	CcSEcCtD
Tiagabine—Dizziness—Varenicline—nicotine dependence	0.0021	0.00268	CcSEcCtD
Tiagabine—Vomiting—Varenicline—nicotine dependence	0.00201	0.00257	CcSEcCtD
Tiagabine—Rash—Varenicline—nicotine dependence	0.002	0.00255	CcSEcCtD
Tiagabine—Dermatitis—Varenicline—nicotine dependence	0.002	0.00255	CcSEcCtD
Tiagabine—Headache—Varenicline—nicotine dependence	0.00198	0.00253	CcSEcCtD
Tiagabine—Nausea—Varenicline—nicotine dependence	0.00188	0.0024	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00142	0.00652	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00133	0.00615	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00132	0.00606	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000228	0.00105	CbGpPWpGaD
